Literature DB >> 8888260

Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography.

W J Matchett1, D R McFarland, D K Russell, D M Sailors, M M Moursi.   

Abstract

In an azotemic patient with suspected renal artery stenosis, undiluted gadopentetate dimeglumine was administered in an aortic bolus to provide contrast at digital subtraction angiography of the aorta and renal arteries. The contrast material (5 mmol/mL) was power injected (rate, 15 mL/sec; total dose, 30 mL). Selective renal arteriography was also performed with 5 mL of undiluted gadopentetate dimeglumine hand injected into each renal artery (total dose, 40 mL). The patient tolerated the procedure without complication or worsening of renal function, and diagnostic angiographic images were obtained.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888260     DOI: 10.1148/radiology.201.2.8888260

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Gadopentetate dimeglumine as a contrast agent in common carotid arteriography.

Authors:  W K Erly; J Zaetta; G T Borders; H Ozgur; D R Gabaeff; R F Carmody; J Seeger
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 3.825

Review 2.  Actual clinical use of gadolinium-chelates for non-MRI applications.

Authors:  Holger M Strunk; H Schild
Journal:  Eur Radiol       Date:  2004-02-10       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.